Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders

NCT02586935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorders

Interventions

DRUG: Tideglusib
OTHER: Placebo

Sponsor

Holland Bloorview Kids Rehabilitation Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]